These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
568 related articles for article (PubMed ID: 23142307)
1. Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review. Ozawa S; Mirelman A; Stack ML; Walker DG; Levine OS Vaccine; 2012 Dec; 31(1):96-108. PubMed ID: 23142307 [TBL] [Abstract][Full Text] [Related]
2. Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries. Deogaonkar R; Hutubessy R; van der Putten I; Evers S; Jit M BMC Public Health; 2012 Oct; 12():878. PubMed ID: 23072714 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia. Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163 [TBL] [Abstract][Full Text] [Related]
5. Influenza vaccines in low and middle income countries: a systematic review of economic evaluations. Ott JJ; Klein Breteler J; Tam JS; Hutubessy RC; Jit M; de Boer MR Hum Vaccin Immunother; 2013 Jul; 9(7):1500-11. PubMed ID: 23732900 [TBL] [Abstract][Full Text] [Related]
6. Economic Analysis of Children's Surgical Care in Low- and Middle-Income Countries: A Systematic Review and Analysis. Saxton AT; Poenaru D; Ozgediz D; Ameh EA; Farmer D; Smith ER; Rice HE PLoS One; 2016; 11(10):e0165480. PubMed ID: 27792792 [TBL] [Abstract][Full Text] [Related]
7. Cost Effectiveness of Pneumococcal Vaccination in Children in Low- and Middle-Income Countries: A Systematic Review. Saokaew S; Rayanakorn A; Wu DB; Chaiyakunapruk N Pharmacoeconomics; 2016 Dec; 34(12):1211-1225. PubMed ID: 27510721 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis. Sinha A; Levine O; Knoll MD; Muhib F; Lieu TA Lancet; 2007 Feb; 369(9559):389-96. PubMed ID: 17276779 [TBL] [Abstract][Full Text] [Related]
9. Epidemiological and Economic Impact of Monovalent and Pentavalent Rotavirus Vaccines in Low and Middle Income Countries: A Cost-effectiveness Modeling Analysis. Paternina-Caicedo A; De la Hoz-Restrepo F; Alvis-Guzmán N Pediatr Infect Dis J; 2015 Jul; 34(7):e176-84. PubMed ID: 25923424 [TBL] [Abstract][Full Text] [Related]
10. Global economic evaluations of rotavirus vaccines: A systematic review. Kotirum S; Vutipongsatorn N; Kongpakwattana K; Hutubessy R; Chaiyakunapruk N Vaccine; 2017 Jun; 35(26):3364-3386. PubMed ID: 28504193 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of health systems strengthening interventions in improving maternal and child health in low- and middle-income countries: a systematic review. Zeng W; Li G; Ahn H; Nguyen HTH; Shepard DS; Nair D Health Policy Plan; 2018 Mar; 33(2):283-297. PubMed ID: 29253136 [TBL] [Abstract][Full Text] [Related]
12. Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies. Leech AA; Kim DD; Cohen JT; Neumann PJ Value Health; 2018 Jul; 21(7):759-761. PubMed ID: 30005746 [TBL] [Abstract][Full Text] [Related]
13. The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study. Portnoy A; Clark RA; Quaife M; Weerasuriya CK; Mukandavire C; Bakker R; Deol AK; Malhotra S; Gebreselassie N; Zignol M; Sim SY; Hutubessy RCW; Baena IG; Nishikiori N; Jit M; White RG; Menzies NA PLoS Med; 2023 Jan; 20(1):e1004155. PubMed ID: 36693081 [TBL] [Abstract][Full Text] [Related]
14. Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country. Burger EA; Campos NG; Sy S; Regan C; Kim JJ Vaccine; 2018 Aug; 36(32 Pt A):4823-4829. PubMed ID: 29807710 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of norovirus vaccination in children in Peru. Mirelman AJ; Ballard SB; Saito M; Kosek MN; Gilman RH Vaccine; 2015 Jun; 33(27):3084-91. PubMed ID: 25980428 [TBL] [Abstract][Full Text] [Related]
16. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA). Kim JJ; Sharma M; O'Shea M; Sweet S; Diaz M; Sancho-Garnier H; Seoud M Vaccine; 2013 Dec; 31 Suppl 6():G65-77. PubMed ID: 24331822 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of surgery in low- and middle-income countries: a systematic review. Grimes CE; Henry JA; Maraka J; Mkandawire NC; Cotton M World J Surg; 2014 Jan; 38(1):252-63. PubMed ID: 24101020 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness. Pearson CAB; Bozzani F; Procter SR; Davies NG; Huda M; Jensen HT; Keogh-Brown M; Khalid M; Sweeney S; Torres-Rueda S; ; ; Eggo RM; Vassall A; Jit M PLoS Med; 2021 Oct; 18(10):e1003815. PubMed ID: 34606520 [TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries. Cook J; Jeuland M; Whittington D; Poulos C; Clemens J; Sur D; Anh DD; Agtini M; Bhutta Z; Vaccine; 2008 Nov; 26(50):6305-16. PubMed ID: 18835415 [TBL] [Abstract][Full Text] [Related]